Secukinumab for the treatment of SAM syndrome associated with desmoglein-1 deficiency.
Br J Dermatol
; 184(4): 770-772, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33205394
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Exfoliative
/
Antibodies, Monoclonal, Humanized
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Br J Dermatol
Year:
2021
Document type:
Article